Loading...
DSM-Firmenich AG
DSFIR.AS•EURONEXT
Consumer Defensive
Household & Personal Products
€89.84
€-0.26(-0.29%)
DSM-Firmenich AG (DSFIR.AS) Financial Performance & Statements
Review DSM-Firmenich AG’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
20.44%
↑ 20.44%
Operating Income Growth
212.88%
↑ 212.88%
Net Income Growth
138.34%
↑ 138.34%
Operating Cash Flow Growth
40.55%
↑ 40.55%
Operating Margin
1.003%
↑ 1.003%
Gross Margin
29.71%
↑ 29.71%
Net Profit Margin
-0.79%
↓ 0.79%
ROE
-0.33%
↓ 0.33%
ROIC
0.32%
↑ 0.32%
DSM-Firmenich AG (DSFIR.AS) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for DSM-Firmenich AG stock.
| Metric | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $3.15B | $3.15B | $3.08B | $3.08B |
| Cost of Revenue | $2.06B | $2.06B | $2.48B | $2.48B |
| Gross Profit | $1.09B | $1.09B | $601.50M | $601.50M |
| Gross Profit Ratio | $0.35 | $0.35 | $0.20 | $0.20 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expenses | $1.01B | $1.01B | $668.00M | $668.00M |
| Total Costs & Expenses | $3.07B | $3.07B | $3.15B | $3.15B |
| Interest Income | $0.00 | $23.00M | $36.50M | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $297.50M | $297.50M | $145.50M | $207.00M |
| EBITDA | $376.00M | $376.00M | $82.50M | $144.00M |
| EBITDA Ratio | $0.12 | $0.12 | $0.03 | $0.05 |
| Operating Income | $78.50M | $78.50M | -$63.00M | -$63.00M |
| Operating Income Ratio | $0.02 | $0.02 | -$0.02 | -$0.02 |
| Other Income/Expenses (Net) | -$24.00M | -$24.00M | -$40.00M | -$40.00M |
| Income Before Tax | $54.50M | $54.50M | -$103.00M | -$103.00M |
| Income Before Tax Ratio | $0.02 | $0.02 | -$0.03 | -$0.03 |
| Income Tax Expense | $29.50M | $29.50M | $9.00M | $9.00M |
| Net Income | $21.00M | $21.00M | -$116.00M | -$116.00M |
| Net Income Ratio | $0.007 | $0.007 | -$0.04 | -$0.04 |
| EPS | $0.08 | $0.08 | -$0.44 | -$0.44 |
| Diluted EPS | $0.08 | $0.08 | -$0.44 | -$0.44 |
| Weighted Avg Shares Outstanding | $265.001M | $265.001M | $265.80M | $265.80M |
| Weighted Avg Shares Outstanding (Diluted) | $265.00M | $265.00M | $265.80M | $265.80M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan